首页> 外国专利> compound and a pharmaceutically acceptable salt or prodrug or solvate thereof, composition, methods of inhibiting checkpoint kinase 1 in a cell, of sensitizing cells in an individual undergoing chemotherapeutic or radiotherapeutic treatment for a medical condition and of inhibiting aberrant cell proliferation, use of a compound, and article of manufacture for pharmaceutical use in human

compound and a pharmaceutically acceptable salt or prodrug or solvate thereof, composition, methods of inhibiting checkpoint kinase 1 in a cell, of sensitizing cells in an individual undergoing chemotherapeutic or radiotherapeutic treatment for a medical condition and of inhibiting aberrant cell proliferation, use of a compound, and article of manufacture for pharmaceutical use in human

机译:化合物及其药学上可接受的盐或前药或溶剂化物,组合物,抑制细胞中检查点激酶1的方法,敏化接受化学疗法或放射疗法治疗的个体的细胞以治疗医学病症以及抑制异常细胞增殖的方法,以及用于人类的药用产品

摘要

COMPOUND AND A PHARMACEUTICALLY ACCEPTABLE SALT OR PRODUCT OR SOLVATE OF THE SAME, COMPOSITION, METHODS OF INHIBITING A CELL POINT KINASE 1, OF SENSITIZING CELLS IN A MATERIAL AND A PASSATIC TRADIUM BY A PASTERIC DIAGNOSIS OF INHIBITING OPEN CELL PROLIFERATION, USE OF A COMPOUND, AND MANUFACTURING ARTICLE FOR PHARMACEUTICAL USE IN HUMAN Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or DNA replication damage are disclosed. Methods of manufacturing the compounds and their use as therapeutic agents, for example in the treatment of cancer and other diseases characterized by defects in DNA replication, chromosome segregation or cell division are also disclosed.
机译:化合物和药物可接受的盐或相同产物或产物的溶剂化物,组成,抑制细胞点激酶1的方法,通过对材料的诊断性细胞和被动式T的抑制作用的成因诊断,从而抑制开放细胞增殖,公开了用于人类的药物和制造制品,其替代的脲化合物可用于治疗与DNA损伤或DNA复制损伤有关的疾病和状况。还公开了化合物的制备方法及其作为治疗剂的用途,例如用于治疗以DNA复制,染色体分离或细胞分裂缺陷为特征的癌症和其他疾病。

著录项

  • 公开/公告号BRPI0512891A

    专利类型

  • 公开/公告日2008-04-15

    原文格式PDF

  • 申请/专利权人 ICOS CORPORATION;

    申请/专利号BR2005PI12891

  • 发明设计人 JOHN JOSEPH GAUDINO;ADAM WADE COOK;

    申请日2005-07-01

  • 分类号C07D401/12;A61K31/17;A61K31/497;C07D413/12;C07D417/12;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:47

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号